UK markets closed

BioCryst Pharmaceuticals, Inc. (BO1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.6960-0.1360 (-2.81%)
At close: 01:30PM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts12121112
Avg. Estimate-0.3-0.27-1.16-0.74
Low estimate-0.38-0.36-1.34-1.38
High estimate-0.19-0.08-0.87-0.05
Year ago EPS-0.26-0.34-1.09-1.16
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts10101011
Avg. Estimate40.22M49.16M156.06M244.59M
Low estimate35M40.5M145M190M
High estimate49M67M181.9M319.4M
Year ago sales3.6M4.02M17.81M156.06M
Sales growth (year/est)1,017.20%1,124.10%776.20%56.70%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.25-0.25-0.27-0.24
Actual EPS-0.26-0.34-0.36-0.24
Difference-0.01-0.09-0.090
Surprise %-4.00%-36.00%-33.30%0.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.3-0.27-1.16-0.74
7 days ago-0.3-0.27-1.16-0.74
30 days ago-0.3-0.27-1.16-0.74
60 days ago-0.27-0.24-1.11-0.74
90 days ago-0.27-0.24-1.11-0.73
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBO1.FIndustrySector(s)S&P 500
Current qtr.-15.40%N/AN/AN/A
Next qtr.20.60%N/AN/AN/A
Current year-6.40%N/AN/AN/A
Next year36.20%N/AN/AN/A
Next 5 years (per annum)58.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A